It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

ANSWER Clinical Study

Clinical Trial Title: 
Adjunctive neurovascular support for wind-neck-aneurysm embolization and reconstruction (ANSWER) clinical study
Clinical Trial Protocol ID: 
13101604
Clinical Trial Investigator Name: 
Demetrius Lopes, MD
Clinical Trial Protocol Description: 

This is a prospective, multi-center, single-arm, non-randomized study. It is designed to evaluate the safety of the PulseRider in patients undergoing treatment for bifurcation basilar or carotid terminus aneurysms.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have intracranial aneurysms located at a bifurcation of the basilar artery or carotid terminus artery.
  • Be 18 years or older at the time of consent.

You will be excluded from the study if any of the following criteria apply to you:

  • Subarachnoid hemorrhage (SAH) within the last 60 days
  • Other conditions of the heart, blood, brain or intracranial vessels that carry a high risk of neurologic events
  • Patient has another aneurysm which, in the investigator’s opinion, will  require treatment within the follow-up period (365 days)

This is a partial list of elgibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Stroke and Cerebrovascular Disease
Contact Email: 
Contact Phone: 
(312) 942-1489
Contact Name: 
Christy Anton, CCRC